Rich M W
Geriatric Cardiology Section, Barnes-Jewish Hospital, Washington University Medical Center, St. Louis, Missouri 63110, USA.
J Am Geriatr Soc. 1997 Aug;45(8):968-74. doi: 10.1111/j.1532-5415.1997.tb02968.x.
To review the epidemiology, pathophysiology, and etiology of congestive heart failure (CHF) in older adults.
Published reports relevant to the epidemiology, pathophysiology, and etiology of CHF were systematically reviewed. Studies involving older adults and more recent studies were emphasized.
More than 75% of patients with CHF in the United States are older than 65 years of age, and CHF is the leading cause of hospitalization in older adults. CHF is also a major cause of chronic disability, and annual expenditures for CHF currently exceed $10 billion. In addition, both the incidence and prevalence of CHF are increasing, largely as a result of the aging of the population. Older adults are predisposed to developing CHF as a result of age-related changes in the cardiovascular system and the high prevalence of hypertension, coronary artery disease, and valvular heart disease in this age group. Although the fundamental pathophysiology of CHF is similar in younger and older patients, older individuals are more prone to develop CHF in the setting of preserved left ventricular systolic function. This syndrome, referred to as diastolic heart failure, accounts for up to 50% of all cases of CHF in adults more than 65 years of age. Coronary heart disease and hypertension are the most common etiologies of CHF in older adults, and they often coexist. Valvular heart disease, especially aortic stenosis and mitral regurgitation, are also common in older adults, whereas nonischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy occur less frequently.
Congestive heart failure is a major public health problem in the United States today as a result of its high and increasing prevalence in the older population as well as its substantial impact on healthcare costs and quality of life. There is an urgent need to develop more effective strategies for the prevention and treatment of CHF in older individuals.
回顾老年人充血性心力衰竭(CHF)的流行病学、病理生理学及病因。
系统回顾已发表的与CHF流行病学、病理生理学及病因相关的报告。重点关注涉及老年人的研究及近期研究。
美国超过75%的CHF患者年龄大于65岁,CHF是老年人住院的主要原因。CHF也是慢性残疾的主要原因,目前CHF的年度支出超过100亿美元。此外,CHF的发病率和患病率均在上升,这主要是人口老龄化的结果。由于心血管系统的年龄相关变化以及该年龄组中高血压、冠状动脉疾病和心脏瓣膜病的高患病率,老年人易患CHF。尽管CHF的基本病理生理学在年轻和老年患者中相似,但老年人在左心室收缩功能保留的情况下更易发生CHF。这种综合征被称为舒张性心力衰竭,在65岁以上的成年人中占所有CHF病例的50%。冠心病和高血压是老年人CHF最常见的病因,且常并存。心脏瓣膜病,尤其是主动脉瓣狭窄和二尖瓣反流,在老年人中也很常见,而非缺血性扩张型心肌病、肥厚型心肌病和限制型心肌病的发生率较低。
由于充血性心力衰竭在老年人群中的高患病率及其不断上升,以及对医疗成本和生活质量的重大影响,它是当今美国的一个主要公共卫生问题。迫切需要制定更有效的策略来预防和治疗老年人的CHF。